Biodefense Market Size, Segments, and Trends by 2031
Biodefense Market: Strategic Insights
Biodefense Market
-
CAGR (2023 - 2031)6.1% -
Market Size 2021
US$ 12.37 Billion -
Market Size 2031
US$ 21.62 Billion
Market Dynamics
GROWTH DRIVERS
- Presence of Favourable Government Initiatives
- Increasing Threat of Biological and Nuclear Weapons
FUTURE TRENDS
- Predictive Analytics to Reshape Biodefense Market
OPPORTUNITIES
- Low R&D Funding by Government in Developing and Underdeveloped Economies
Key Players
- Bavarian Nordic
- Alnylam Pharmaceuticals Inc
- SIGA Technologies
- Emergent BioSolutions Inc
- Cleveland Bio Labs
- Dynavax Technologies
- Elusys Therapeutics Inc
- Soligenix
- Altimmune
- Pluristem
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Anthrax
- Smallpox
- Botulism
- Radiation
- Nuclear
Get Free Sample For